Ethan Daniels, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Mohammed S Qayyum MD Inc · 4 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Daniels’s office at (408) 610-2001 to ask if they take your plan before you enroll.
California Medical Board record
Licence G56875 · Current
Licensed to practise in California · since 1986 · expires 2028-03-31 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$63,537
Medicare paid this office $63,537 for 222 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 132 | $34,107 | $159 |
| Return visit (30+ min) | 89 | $14,827 | $114 |
| New patient visit (60+ min) | 32 | $6,035 | $189 |
| Evaluation of cardiac rhythm monitor system | 23 | $2,221 | $49 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $2,028 | $61 |
See all 7 services
| Long return visit (40+ min) | 132 | $34,107 | $159 |
| Return visit (30+ min) | 89 | $14,827 | $114 |
| New patient visit (60+ min) | 32 | $6,035 | $189 |
| Evaluation of cardiac rhythm monitor system | 23 | $2,221 | $49 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $2,028 | $61 |
| Programming of dual lead pacemaker system | 11 | $1,106 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 41 | $632 | $14 |
Who their Medicare patients are
222 Original Medicare patients in 2024. Average age 78 · Women 50% · Also on Medicaid 5% · Health risk score 1.29. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 75% · Diabetes 35% · Heart failure 35% · Atrial fibrillation 34% · Chronic kidney disease 24% · Cancer 18% · COPD 16% · Stroke 13% · Depression 12% · Dementia 12%.
The office billed $157,098, Medicare allowed $85,993 and paid $63,537; for 544 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 222 | 544 | 78 | 1.29 | $157,098 | $63,537 |
| 2023 | 238 | 575 | 77 | 1.40 | $169,754 | $67,062 |
| 2022 | 201 | 517 | 78 | 1.40 | $139,686 | $61,698 |
| 2021 | 193 | 510 | 78 | 1.38 | $136,570 | $58,786 |
| 2020 | 173 | 425 | 77 | 1.52 | $117,650 | $41,254 |
| 2019 | 47 | 71 | 69 | 2.77 | $16,611 | $4,530 |
| 2018 | 63 | 87 | 68 | 2.95 | $11,095 | $2,758 |
| 2017 | 60 | 88 | 70 | 2.86 | $7,953 | $1,721 |
| 2016 | 48 | 72 | 71 | 2.93 | $6,056 | $1,428 |
| 2015 | 11 | 16 | 71 | 3.63 | $11,913 | $1,768 |
| 2014 | 34 | 56 | 72 | 2.91 | $24,869 | $5,674 |
| 2013 | 21 | 24 | 72 | 2.62 | $16,116 | $3,559 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 138 | $30,229 | $157 |
| Return visit (30+ min) | 111 | $17,766 | $115 |
| New patient visit (60+ min) | 47 | $8,994 | $191 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $2,298 | $62 |
| Evaluation of cardiac rhythm monitor system | 23 | $1,820 | $52 |
| Programming of dual lead pacemaker system | 14 | $1,632 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 55 | $836 | $14 |
2022: 6 services
| Long return visit (40+ min) | 142 | $31,967 | $162 |
| Return visit (30+ min) | 97 | $17,786 | $114 |
| New patient visit (60+ min) | 27 | $4,849 | $180 |
| Evaluation of cardiac rhythm monitor system | 24 | $2,311 | $54 |
| Programming of dual lead pacemaker system | 14 | $1,525 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $617 | $14 |
2021: 7 services
| Long return visit (40+ min) | 102 | $22,248 | $157 |
| Return visit (30+ min) | 103 | $19,714 | $121 |
| New patient visit (60+ min) | 52 | $10,306 | $198 |
| Programming of dual lead pacemaker system | 13 | $1,699 | $81 |
| Evaluation of cardiac rhythm monitor system | 17 | $1,477 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 66 | $1,058 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 13 | $849 | $65 |
2020: 5 services
| Long return visit (40+ min) | 88 | $15,218 | $130 |
| Return visit (30+ min) | 76 | $11,142 | $94 |
| New patient visit (60+ min) | 45 | $8,374 | $186 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 22 | $1,496 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 66 | $1,187 | $17 |
2019: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $228 | $7 |
2018: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 41 | $314 | $7 |
2017: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 44 | $326 | $6 |
2016: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 38 | $328 | $7 |
2014: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 18 | $166 | $7 |
Medicaid work
$65,598 in 2021
Medicaid paid $65,598 for 395 billed services this clinician did in 2021, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 269 | $65,091 |
| New patient visit (60+ min) | 80 | $476 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 30 | $32 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 16 | $0 |
| 2021 | 395 | 4 | 42 | $65,598 |
| 2020 | 564 | 4 | 33 | $80,338 |
| 2019 | 199 | 3 | 28 | $10,698 |
| 2018 | 158 | 1 | 34 | $218 |
See the largest Medicaid services in earlier years
2020
| Clinic visit/encounter, all-inclusive | 372 | $79,095 |
| New patient visit (60+ min) | 84 | $827 |
| Return visit (30+ min) | 80 | $356 |
| Short return visit (20+ min) | 28 | $60 |
2019
| Clinic visit/encounter, all-inclusive | 42 | $10,394 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 102 | $161 |
| Short return visit (20+ min) | 55 | $144 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 158 | $218 |
Drugs they prescribed that Part D paid
$87,055
Pharmacies billed $87,055 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 390) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
323 generic and 67 brand-name prescriptions · $87,055 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 33 | $42,157 | $1,277 |
| Eliquis | 14 | $23,771 | $1,698 |
| Rosuvastatin | 76 | $745 | $10 |
| Ezetimibe | 19 | $467 | $25 |
| Amlodipine Besylate | 67 | $463 | $7 |
See all 9 drugs
| Xarelto | 33 | $42,157 | $1,277 |
| Eliquis | 14 | $23,771 | $1,698 |
| Rosuvastatin | 76 | $745 | $10 |
| Ezetimibe | 19 | $467 | $25 |
| Amlodipine Besylate | 67 | $463 | $7 |
| Metoprolol | 49 | $407 | $8 |
| Sotalol | 13 | $342 | $26 |
| Carvedilol | 21 | $272 | $13 |
| Losartan | 29 | $188 | $6 |
Year by year
| 2024 | 390 | 91 | 0% (0) | 17% | $87,055 |
| 2023 | 270 | 86 | 0% (0) | None | $53,155 |
| 2022 | 243 | 77 | 0% (0) | 13% | $35,829 |
| 2021 | 278 | 92 | 0% (0) | 14% | $41,415 |
| 2020 | 328 | 139 | 0% (0) | 15% | $31,281 |
| 2019 | 884 | 254 | None | 24% | $101,480 |
| 2018 | 880 | 251 | 0% (0) | 30% | $87,455 |
| 2017 | 811 | 213 | 0% (0) | 31% | $71,110 |
| 2016 | 650 | 177 | 0% (0) | 26% | $47,104 |
| 2015 | 649 | 174 | 0% (0) | 26% | $32,759 |
| 2014 | 860 | 212 | None | None | $48,578 |
| 2013 | 780 | 184 | None | 18% | $43,753 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Xarelto | 19 | $31,741 | $1,671 |
| Repatha Sureclick | 12 | $6,831 | $569 |
| Rosuvastatin | 57 | $1,028 | $18 |
| Metoprolol | 42 | $676 | $16 |
| Ezetimibe | 16 | $506 | $32 |
| Sotalol | 18 | $447 | $25 |
| Amlodipine Besylate | 33 | $195 | $6 |
2022: 7 drugs
| Xarelto | 12 | $17,291 | $1,441 |
| Rosuvastatin | 43 | $1,921 | $45 |
| Ezetimibe | 13 | $841 | $65 |
| Metoprolol | 49 | $693 | $14 |
| Sotalol | 13 | $403 | $31 |
| Amlodipine Besylate | 14 | $280 | $20 |
| Carvedilol | 12 | $123 | $10 |
2021: 7 drugs
| Xarelto | 19 | $22,052 | $1,161 |
| Metoprolol | 51 | $1,313 | $26 |
| Rosuvastatin | 38 | $1,204 | $32 |
| Isosorbide Mononitrate Er | 15 | $276 | $18 |
| Amlodipine Besylate | 22 | $250 | $11 |
| Carvedilol | 15 | $173 | $12 |
| Furosemide | 15 | $76 | $5 |
2020: 12 drugs
| Xarelto | 13 | $11,792 | $907 |
| Rosuvastatin | 27 | $1,124 | $42 |
| Flecainide Acetate | 11 | $842 | $77 |
| Metoprolol | 23 | $534 | $23 |
| Atorvastatin | 26 | $507 | $19 |
| Amiodarone | 20 | $506 | $25 |
| Metoprolol | 31 | $263 | $8 |
| Furosemide | 21 | $205 | $10 |
| Carvedilol | 17 | $205 | $12 |
| Losartan | 13 | $162 | $12 |
| Lisinopril | 12 | $125 | $10 |
| Amlodipine Besylate | 11 | $73 | $7 |
2019: 16 drugs
| Pradaxa | 74 | $34,332 | $464 |
| Eliquis | 32 | $30,791 | $962 |
| Flecainide Acetate | 86 | $4,049 | $47 |
| Atorvastatin | 74 | $1,815 | $25 |
| Dilt-Xr | 19 | $1,636 | $86 |
| Amiodarone | 67 | $1,568 | $23 |
| Metoprolol | 39 | $1,199 | $31 |
| Metoprolol | 106 | $1,042 | $10 |
| Furosemide | 57 | $628 | $11 |
| Lisinopril | 42 | $479 | $11 |
| Clopidogrel | 16 | $405 | $25 |
| Carvedilol | 39 | $394 | $10 |
| Losartan | 29 | $324 | $11 |
| Nitroglycerin | 13 | $297 | $23 |
| Atenolol | 27 | $258 | $10 |
| Simvastatin | 14 | $149 | $11 |
2018: 19 drugs
| Pradaxa | 68 | $25,837 | $380 |
| Eliquis | 30 | $18,956 | $632 |
| Flecainide Acetate | 95 | $5,305 | $56 |
| Atorvastatin | 67 | $1,873 | $28 |
| Metoprolol | 133 | $1,298 | $10 |
| Amiodarone | 61 | $1,242 | $20 |
| Dilt-Xr | 12 | $682 | $57 |
| Furosemide | 56 | $672 | $12 |
| Clopidogrel | 23 | $664 | $29 |
| Lisinopril | 50 | $558 | $11 |
| Atenolol | 38 | $462 | $12 |
| Losartan | 26 | $377 | $14 |
| Nitroglycerin | 14 | $364 | $26 |
| Sotalol | 11 | $299 | $27 |
| Isosorbide Mononitrate Er | 20 | $253 | $13 |
| Carvedilol | 25 | $252 | $10 |
| Hydralazine | 12 | $175 | $15 |
| Simvastatin | 14 | $161 | $11 |
| Amoxicillin | 14 | $88 | $6 |
2017: 17 drugs
| Pradaxa | 74 | $23,333 | $315 |
| Eliquis | 13 | $7,629 | $587 |
| Flecainide Acetate | 63 | $4,389 | $70 |
| Atorvastatin | 62 | $1,875 | $30 |
| Amiodarone | 47 | $1,139 | $24 |
| Metoprolol | 103 | $979 | $10 |
| Clopidogrel | 28 | $863 | $31 |
| Dilt-Xr | 11 | $598 | $54 |
| Furosemide | 49 | $540 | $11 |
| Nitroglycerin | 18 | $531 | $29 |
| Losartan | 27 | $524 | $19 |
| Sotalol | 15 | $474 | $32 |
| Lisinopril | 40 | $463 | $12 |
| Atenolol | 30 | $390 | $13 |
| Isosorbide Mononitrate Er | 33 | $378 | $11 |
| Carvedilol | 30 | $327 | $11 |
| Simvastatin | 18 | $223 | $12 |
2016: 17 drugs
| Pradaxa | 34 | $13,674 | $402 |
| Flecainide Acetate | 44 | $6,179 | $140 |
| Atorvastatin | 61 | $1,915 | $31 |
| Nitrostat | 14 | $914 | $65 |
| Sotalol | 13 | $780 | $60 |
| Metoprolol | 77 | $780 | $10 |
| Amiodarone | 27 | $680 | $25 |
| Clopidogrel | 18 | $675 | $37 |
| Lisinopril | 51 | $598 | $12 |
| Simvastatin | 23 | $418 | $18 |
| Isosorbide Mononitrate Er | 38 | $399 | $11 |
| Losartan | 17 | $388 | $23 |
| Carvedilol | 31 | $335 | $11 |
| Atenolol | 28 | $333 | $12 |
| Furosemide | 29 | $314 | $11 |
| Warfarin | 13 | $165 | $13 |
| Lovastatin | 12 | $140 | $12 |
2015: 15 drugs
| Pradaxa | 31 | $8,897 | $287 |
| Flecainide Acetate | 33 | $5,306 | $161 |
| Atorvastatin | 89 | $2,718 | $31 |
| Clopidogrel | 36 | $1,953 | $54 |
| Pravastatin | 15 | $877 | $58 |
| Lisinopril | 62 | $723 | $12 |
| Simvastatin | 34 | $661 | $19 |
| Losartan | 26 | $596 | $23 |
| Metoprolol | 63 | $583 | $9 |
| Furosemide | 31 | $346 | $11 |
| Carvedilol | 29 | $305 | $11 |
| Atenolol | 28 | $298 | $11 |
| Isosorbide Mononitrate Er | 25 | $275 | $11 |
| Warfarin | 18 | $240 | $13 |
| Lovastatin | 15 | $188 | $13 |
2014: 17 drugs
| Pradaxa | 56 | $12,372 | $221 |
| Flecainide Acetate | 33 | $5,069 | $154 |
| Atorvastatin | 97 | $3,105 | $32 |
| Clopidogrel | 44 | $1,920 | $44 |
| Pravastatin | 28 | $1,556 | $56 |
| Simvastatin | 65 | $1,199 | $18 |
| Metoprolol | 107 | $1,013 | $9 |
| Lisinopril | 69 | $864 | $13 |
| Losartan | 32 | $762 | $24 |
| Nitrostat | 20 | $563 | $28 |
| Atenolol | 48 | $536 | $11 |
| Furosemide | 39 | $474 | $12 |
| Amiodarone | 16 | $365 | $23 |
| Amlodipine Besylate | 11 | $268 | $24 |
| Isosorbide Mononitrate Er | 25 | $266 | $11 |
| Lovastatin | 20 | $241 | $12 |
| Carvedilol | 12 | $128 | $11 |
2013: 16 drugs
| Flecainide Acetate | 31 | $6,645 | $214 |
| Pradaxa | 14 | $5,292 | $378 |
| Clopidogrel | 61 | $3,897 | $64 |
| Simvastatin | 104 | $2,317 | $22 |
| Atorvastatin | 53 | $1,771 | $33 |
| Nitrostat | 34 | $1,076 | $32 |
| Pravastatin | 28 | $1,061 | $38 |
| Lisinopril | 79 | $934 | $12 |
| Metoprolol | 83 | $780 | $9 |
| Losartan | 24 | $646 | $27 |
| Atenolol | 41 | $455 | $11 |
| Amiodarone | 11 | $337 | $31 |
| Lovastatin | 24 | $280 | $12 |
| Furosemide | 22 | $275 | $13 |
| Carvedilol | 18 | $215 | $12 |
| Isosorbide Mononitrate Er | 18 | $210 | $12 |
Money from drug and device companies
$73 in 2025
| 2025 | 1 | 1 | None | $73 |
| 2022 | 2 | 2 | None | $56 |
| 2021 | 10 | 20 | None | $467 |
| 2020 | 12 | 33 | None | $910 |
| 2019 | 5 | 5 | None | $283 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biotronik | Solia | $73 | 1 payment
|
See the published payment
| Biotronik | Meals · 2025-06-22 | Solia | $73 |
See earlier years (2022, 2021, 2020, 2019)
2022: $56
| Actelion Pharmaceuticals US | Opsumit | $37 | 1 payment
|
| Abbott Laboratories | Jot Dx | $19 | 1 payment
|
2021: $467
| Amgen | Repatha | $77 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | None | $75 | 1 payment
|
| Biotronik | Solia | $57 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $56 | 3 payments
|
| Amarin Pharma | Vascepa | $54 | 3 payments
|
| Esperion Therapeutics | Nexletol | $45 | 2 payments
|
| Actelion Pharmaceuticals US | Uptravi | $37 | 2 payments
|
| Regeneron Healthcare Solutions | Evkeeza | $27 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $24 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $14 | 1 payment
|
2020: $910
| Medtronic Vascular | Heartware Hvad | $229 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $150 | 6 payments
|
| Amgen | Repatha | $113 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $103 | 5 payments
|
| Esperion Therapeutics | Nexletol | $64 | 3 payments
|
| Amarin Pharma | Vascepa | $62 | 3 payments
|
| Regeneron Healthcare Solutions | Praluent | $46 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Adempas | $44 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $43 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $21 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $20 | 1 payment
|
| Biotronik | None | $13 | 1 payment
|
2019: $283
| Medtronic Vascular | Azure | $115 | 1 payment
|
| Terumo Medical | Optitorque | $100 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $27 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $21 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $20 | 1 payment
|
Professional record
- NPI
- 1699852558
- Licence
- CA G56875California G56875: Current · expires 2028-03-31
- Trained
- Rush Medical College of Rush University, 1981
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G568750
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 2550 Samaritan Dr Ste D, San Jose, CA, 95124
- NPI first listed
- 2006-10-31
- NPI last updated
- 2019-09-23
This is when the NPI record was last certified, not a medical board exam.